Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy

Atherosclerosis

Volumn 172, Issue 1, 2004, Pages 121-125

  Friedman, Allon N ^a   Hunsicker, Lawrence G ^b   Selhub, Jacob ^c   Bostom, Andrew G ^c,d  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c TUFTS UNIVERSITY   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

Body mass index; C reactive protein; Cardiovascular; Creatinine; Diabetes; Pyridoxal phosphate; Vitamin B6

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATINE; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN A1C; HOMOCYSTEINE; IRBESARTAN; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; SERUM ALBUMIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC NEUROPATHY; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; REGRESSION ANALYSIS; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

EID: 0346094370     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.09.011     Document Type: Article

References (30)

1. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V.et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 100:1999;1134-1146.
2. Dinneen S.F., Gerstein H.C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch. Int. Med. 157:1997;1413-1418.
3. Wollesen F., Brattstrom L., Refsum H., Ueland P.M., Berglund L., Berne C.et al. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int. 55:1999;1028-1035.
4. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
5. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:1997;973-979.
6. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F.M., Moye L.A., Goldman S.et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) investigators. Circulation. 98:1998;839-844.
7. Yeun V., Levine R., Mantadilok V., Kaysen G.A. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am. J. Kidney Dis. 35:2000;469-476.
8. Lewis E.J., Hunsicker L.G., Clarke W.R., Berl T., Pohl M.A., Lewis J.B. et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345:2001;851-860.
9. Araki A., Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 422:1987;43-52.
10. Shin Y.S., Rasshofer R., Friedrich B., Endres W. Pyridoxal-5′- phosphate determination by a sensitive micromethod in human blood, urine and tissues; its relation to cystathioninuria in neuroblastoma and biliary atresia. Clin. Chim. Acta. 127:1983;77-85.
11. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. Bethesda: U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute; 1998. p. 228.
12. Jacques P.F., Selhub J., Bostom A.G., Wilson P.W., Rosenberg I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N. Engl. J. Med. 340:1999;1449-1454.
13. 6 is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation. 103:2001;2788-2791.
14. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:2000;836-843.
15. Ortega O., Rodriguez I., Gallar P., Carreno A., Ortiz M., Espejo B.et al. Significance of high C-reactive protein levels in pre-dialysis patients. Nephrol. Dial Transplant. 17:2002;1105-1109.
16. Selhub J. Homocysteine metabolism. Annu. Rev. Nutr. 19:1999;217-246.
17. 6 deficiency in uremia. Am. J. Clin. Nutr. 28:1975;950-957.
18. Bates C.J., Pentieva K.D., Prentice A., Mansoor M.A., Funch S. Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. Br. J. Nutr. 81:1999;191-201.
19. Roubenoff R., Dellaripa P., Nadeau M.R., Abad L.W., Muldoon B.A., Selhub J.et al. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum. 40:1997;718-722.
20. 6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation. 97:1998;437-443.
21. Visser M., Bouter L., McQuillan G., Wener M.H., Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 282:1999;2131-2135.
22. Ford E. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 22:1999;1971-1977.
23. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82:1997;4196-4200.
24. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., Heath C.W. Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med. 341:1999;1097-1105.
25. Kaysen G.A. The microinflammatory state in uremia: causes and potential consequences. J. Am. Soc. Nephrol. 12:2001;1549-1557.
26. Festa A., D'Agostino R. Jr., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 102:2000;42-47.
27. Anderson J.L., Muhlestein J.B., Horne B.D., Carlquist J.F., Bair T.L., Madsen T.E. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation. 102:2000;1227-1232.
28. Stehouwer C.D., Gall M.A., Twisk J.W., Knudsen E., Emeis J.J., Parving H.H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes. 51:2002;1157-1165.
29. Schalkwijk C.G., Poland D.C., van Dijk W., Kok A., Emeis J.J., Draper A.M. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia. 42:1999;351-357.
30. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int. 58:2000;1703-1710.